Ribeirão Preto College of Nursing, University of São Paulo, Ribeirão Preto, Brazil.
Department of Medicine and Nursing, Federal University of Viçosa, Viçosa, Brazil.
JMIR Res Protoc. 2024 Oct 15;13:e55792. doi: 10.2196/55792.
The increased incidence of breast cancer implies the appearance of frequent symptoms associated with disease and treatments, such as pain. For the management of this issue, auricular therapy has been used in a complementary manner, especially for its safety and analgesic action.
This systematic review aims to summarize available evidence on the effects of auricular therapy on pain in women undergoing breast cancer treatment.
This is a systematic review that includes randomized controlled trials that evaluated the effects of auricular therapy on pain in women with breast cancer, as compared with other interventions (sham or placebo auricular therapy, other nonpharmacological interventions, and routine pain treatments) during the treatment of the disease. Pain, whether induced or not by cancer treatments, is the main outcome to be evaluated. The search for the studies was performed in the following databases: MEDLINE through PubMed, CINAHL, CENTRAL, Embase, Web of Science, Scopus, VHL, TCIM Americas Network, CNKI, and Wanfang Data. The reviewers have independently evaluated the full texts, and in the near future, they will extract the data and assess the risk of bias in the included studies. The certainty of the evidence will be assessed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE), and a meta-analysis will be carried out to evaluate the intervention, considering the homogeneity of the results, using the Cochran Q test and quantified by the Higgins inconsistency index. The guidelines of the PRISMA-P (Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols) have been respected in the elaboration of this protocol.
The records screening stage has been completed, and the synthesis and meta-analysis were conducted in February 2024. We hope to have finished the preparation of the paper for publication by September 2024. Review reporting will follow standard guidelines for reporting systematic reviews. The results will be published in peer-reviewed scientific journals.
This review will compile the strength of evidence for the use of auricular therapy in the management of pain in women with breast cancer during the treatment of the disease, identifying gaps in the available evidence as well as assisting health professionals in indicating the intervention for clinical practice.
PROSPERO CRD42022382433; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=382433.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/55792.
乳腺癌发病率的增加意味着与疾病和治疗相关的频繁症状的出现，例如疼痛。为了管理这个问题，耳穴疗法已经被以一种补充的方式使用，特别是因为它的安全性和镇痛作用。
本系统评价旨在总结现有的关于耳穴疗法对接受乳腺癌治疗的女性疼痛影响的证据。
这是一项系统评价，包括随机对照试验，评估了耳穴疗法对乳腺癌女性疼痛的影响，与其他干预措施（假耳穴疗法、安慰剂耳穴疗法、其他非药物干预措施和常规疼痛治疗）相比，在疾病治疗期间。主要评估的结果是由癌症治疗引起或未引起的疼痛。研究的检索是在以下数据库中进行的：通过 PubMed 进行 MEDLINE、CINAHL、CENTRAL、Embase、Web of Science、Scopus、VHL、TCIM 美洲网络、CNKI 和万方数据。审查员独立评估了全文，并将在不久的将来提取数据并评估纳入研究的偏倚风险。使用 GRADE（推荐评估、制定和评价）评估证据的确定性，并根据结果的同质性使用 Cochran Q 检验和 Higgins 不一致指数进行量化，进行荟萃分析以评估干预措施。在制定该方案时，我们遵循了 PRISMA-P（系统评价和荟萃分析报告的首选项目）指南。
记录筛选阶段已经完成，综合和荟萃分析已于 2024 年 2 月进行。我们希望在 2024 年 9 月之前完成论文的发表准备。综述报告将遵循系统评价报告的标准指南。结果将发表在同行评议的科学期刊上。
本综述将汇编耳穴疗法在乳腺癌女性疾病治疗期间管理疼痛方面的证据强度，确定现有证据中的差距，并协助卫生专业人员为临床实践指明干预措施。
PROSPERO CRD42022382433；https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=382433。
国际注册报告标识符（IRRID）：DERR1-10.2196/55792。
